EMERYVILLE, Calif.--(BUSINESS WIRE)--NovaBay Pharmaceuticals, Inc. (AMEX & TSX: NBY, http://www.novabaypharma.com), a biopharmaceutical company developing products for the treatment or prevention of a wide range of bacterial and viral infections, will present at the New York Society of Security Analysts’ (“NYSSA”) 11th Annual Biotech/Specialty Pharma Conference held at the NYSSA’s headquarters in New York City on Tuesday, December 11 at 3:30PM/EST. The live PowerPoint presentation with streaming video will be webcast and archived for one year at: http://investor.shareholder.com/media/eventdetail.cfm?eventid=47195& CompanyID=NBY&e=1&mediaKey=79860443FCCAECCD93F3C3F9401CFB25.
